Showing promise in the landscape of weight management management, retatrutide is a unique approach. Unlike many current medications, retatrutide functions as a twin agonist, simultaneously affecting both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic hormone (GIP) binding sites. This simultaneous engagement fosters several advantageous